New research shows that the C-terminal tail of IgA subtypes provides an innate line of defense against viruses that use sialic acid as a receptor. This could potentially lead to novel vaccines and therapies for flu.

See the source article by following the link below:
New research shows that the C-terminal tail of IgA subtypes provides an innate line of defense against viruses that use sialic acid as a receptor. This could potentially lead to novel vaccines and therapies for flu.